サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439508

プラークモディフィケーションデバイス - 世界市場の考察、競合情勢、市場予測（2030年）

Plaque Modification Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
プラークモディフィケーションデバイス - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のプラークモディフィケーションデバイスの市場規模は、2023年に12億1,000万米ドル、2030年までに19億3,000万米ドルに達し、2024年～2030年の予測期間にCAGRで8.09％の成長が見込まれます。プラークは、動脈の壁に沈着する脂肪性の蝋状物質です。これらの沈着物は動脈を狭め、血流を低下させます。時にはプラークが破裂し、破裂部位に血栓を作ることもあります。プラークモディフィケーションデバイスに対する需要の増加は主に、世界中の老年人口の継続的な拡大、座りがちなライフスタイルの増加とそれに伴う障害、動脈プラークを発生させる主な危険因子である世界中での人々の肥満の増加などによるものです。加えて、プラークモディフィケーションデバイスの承認と発売、プラークモディフィケーション製品の市場拡大に向けた主要企業の戦略的事業活動などが、世界のプラークモディフィケーションデバイス市場の促進要因となっています。

プラークモディフィケーションデバイスの市場力学

プラークモディフィケーションデバイス市場は、糖尿病や高血圧などの生活習慣病の有病率の増加により、現在勢いを増しています。例えば、糖尿病と高血圧はともに、個人におけるプラークの発生につながり、冠動脈疾患、末梢動脈疾患、動脈瘤などの重篤な疾患につながる可能性のある主な危険因子と考えられています。国際糖尿病連合（IDF）のDiabetes Atlas 2021 tenth Editionが発表した統計によると、2023年に5億3,700万人の成人（20～79歳）が糖尿病を患っており、2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると予測されています。

さらに、世界保健機関（WHO）が2023年に明らかにしたデータによると、同年、全世界の30～79歳の成人12億8,000万人が高血圧に罹患していると推定されています。このように、世界中の人々の間で糖尿病と高血圧が増加していることは、プラークモディフィケーションデバイスの市場成長の潜在的要因となる可能性があります。

加えて、年齢もプラーク増殖の主な要因です。National Institute on Agingによると、多くの心臓病は、長年にわたる冠動脈の壁への脂肪沈着物、すなわちプラークの蓄積であるアテローム性動脈硬化症によって引き起こされ、年齢が進むとアテローム性動脈硬化症の発症リスクが高まります。例えば、国連のWorld Population Ageing 2020 Highlightsによると、2020年に世界全体で65歳以上の高齢者が7億2,700万人になると推定されています。

さらに、世界中のさまざまな地域における先進技術を利用したプラーク除去デバイスの承認も、プラークモディフィケーションデバイス市場の成長に寄与する見込みです。例えば、2018年5月、Avinger, Inc.は末梢動脈疾患の治療に向けた史上初の画像誘導アテレクトミーデバイスである次世代Pantheris® LumivascularアテレクトミーシステムのFDA認可を取得しました。

このように、上記のすべての要因により、今後数年間にプラークモディフィケーションデバイスの需要が急増すると予測されます。

COVID-19パンデミックにより、市場におけるプラークモディフィケーションデバイスの需要は減少しました。これは、多くの定期的な処置や外来診療が一時的に中断され、世界の医療施設がロックダウン初期にCOVID-19患者の負担管理に一時的に注力したためです。しかし、2020年後半に世界中で多数のCOVID-19ワクチンが承認され投与されたおかげで、医療サービスを含むさまざまな領域で活動の再開に大きな改善が見られ、プラークモディフィケーションデバイス市場の健全な回復期への道が開かれました。

しかし、プラークモディフィケーションデバイスの厳しい規制承認プロセスや、デバイスや外科手術に関連する合併症が、プラークモディフィケーションデバイス市場の成長を抑制する可能性が高いです。

当レポートでは、世界のプラークモディフィケーションデバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 プラークモディフィケーションデバイス市場レポートのイントロダクション

第2章 プラークモディフィケーションデバイス市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制と特許の分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 プラークモディフィケーションデバイス市場の主な要因の分析

  • プラークモディフィケーションデバイス市場の促進要因
    • 座りがちなライフスタイルの増加、糖尿病、高血圧、肥満などの生活習慣病の有病率の増加
    • 老年人口の増加
    • 低侵襲手術に対する選好の高まり
    • 先進技術を利用した製品の承認と発売の増加
  • プラークモディフィケーションデバイス市場の抑制要因と課題
    • プラークモディフィケーションデバイスや手術に伴う高いコストと合併症
    • 厳格な規制当局の承認プロセス
  • プラークモディフィケーションデバイス市場の機会
    • 低中所得国における成長機会
    • 主要企業の戦略的事業活動が市場拡大の機会をもたらす

第5章 プラークモディフィケーションデバイスのポーターのファイブフォース分析

第6章 プラークモディフィケーションデバイス市場に対するCOVID-19の影響分析

第7章 プラークモディフィケーションデバイス市場レイアウト

  • 製品タイプ別
    • アテレクトミーデバイス
    • 血栓除去デバイス
    • 慢性完全閉塞（CTO）デバイス
    • 塞栓防止デバイス
    • その他
  • 用途別
    • 冠動脈疾患
    • 末梢動脈疾患
    • 神経血管疾患
  • エンドユーザー
    • 病院
    • 外来手術センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 プラークモディフィケーションデバイス：世界の企業シェア分析 - 主要3～5社

第9章 プラークモディフィケーションデバイスの企業と製品のプロファイル

  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Shockwave Medical, Inc.
  • Cardiovascular Systems, Inc.
  • AngioDynamics, Inc.
  • Avinger
  • REX MEDICAL
  • Ra Medical Systems
  • Koninklijke Philips N.V.
  • Rontis Corporation
  • Becton, Dickinson and Company
  • Penumbra, Inc.
  • Stryker
  • Microvention, Inc.
  • Johnson & Johnson
  • ARGON MEDICAL.
  • Inari Medical
  • Nitiloop
  • Soundbite Medical Solutions

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Plaque Modification Devices Market
  • Table 3 Plaque Modification Devices Market Analysis in Global (2021-2030)
  • Table 4 Plaque Modification Devices Market Analysis in Global by Product Type (2021-2030)
  • Table 5 Plaque Modification Devices Market Analysis in Global by Application (2021-2030)
  • Table 6 Plaque Modification Devices Market Analysis in Global by End User (2021-2030)
  • Table 7 Plaque Modification Devices Market Analysis in Global by Geography (2021-2030)
  • Table 8 Plaque Modification Devices Market Analysis in North America (2021-2030)
  • Table 9 Plaque Modification Devices Market Analysis in North America by Product Type (2021-2030)
  • Table 10 Plaque Modification Devices Market Analysis in North America by Application (2021-2030)
  • Table 11 Plaque Modification Devices Market Analysis in North America by End User (2021-2030)
  • Table 12 Plaque Modification Devices Market Analysis in North America by Country (2021-2030)
  • Table 13 Plaque Modification Devices Market Analysis in the US (2021-2030)
  • Table 14 Plaque Modification Devices Market Analysis in Canada (2021-2030)
  • Table 15 Plaque Modification Devices Market Analysis in Mexico (2021-2030)
  • Table 16 Plaque Modification Devices Market Analysis in Europe (2021-2030)
  • Table 17 Plaque Modification Devices Market Analysis in Europe by Product Type (2021-2030)
  • Table 18 Plaque Modification Devices Market Analysis in Europe by Application (2021-2030)
  • Table 19 Plaque Modification Devices Market Analysis in Europe by End User (2021-2030)
  • Table 20 Plaque Modification Devices Market Analysis in Europe by Country (2021-2030)
  • Table 21 Plaque Modification Devices Market Analysis in France (2021-2030)
  • Table 22 Plaque Modification Devices Market Analysis in Germany (2021-2030)
  • Table 23 Plaque Modification Devices Market Analysis in the UK (2021-2030)
  • Table 24 Plaque Modification Devices Market Analysis in Italy (2021-2030)
  • Table 25 Plaque Modification Devices Market Analysis in Spain (2021-2030)
  • Table 26 Plaque Modification Devices Market Analysis in Russia (2021-2030)
  • Table 27 Plaque Modification Devices Market Analysis in Rest of Europe (2021-2030)
  • Table 28 Plaque Modification Devices Market Analysis in Asia-Pacific (2021-2030)
  • Table 29 Plaque Modification Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Table 30 Plaque Modification Devices Market Analysis in Asia-Pacific by Application (2021-2030)
  • Table 31 Plaque Modification Devices Market Analysis in Asia-Pacific by End User (2021-2030)
  • Table 32 Plaque Modification Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 33 Plaque Modification Devices Market Analysis in China (2021-2030)
  • Table 34 Plaque Modification Devices Market Analysis in Japan (2021-2030)
  • Table 35 Plaque Modification Devices Market Analysis in India (2021-2030)
  • Table 36 Plaque Modification Devices Market Analysis in Australia (2021-2030)
  • Table 37 Plaque Modification Devices Market Analysis in South Korea (2021-2030)
  • Table 38 Plaque Modification Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 39 Plaque Modification Devices Market Analysis in Rest of World (2021-2030)
  • Table 40 Plaque Modification Devices Market Analysis in Rest of World by Product Type (2021-2030)
  • Table 41 Plaque Modification Devices Market Analysis in Rest of World by Application (2021-2030)
  • Table 42 Plaque Modification Devices Market Analysis in Rest of World by End User (2021-2030)
  • Table 43 Plaque Modification Devices Market Analysis in Rest of World by Country (2021-2030)
  • Table 44 Plaque Modification Devices Market Analysis in the Middle East (2021-2030)
  • Table 45 Plaque Modification Devices Market Analysis in Africa (2021-2030)
  • Table 46 Plaque Modification Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Plaque Modification Devices Market
  • Figure 3 Plaque Modification Devices Market Analysis in Global (2021-2030)
  • Figure 4 Plaque Modification Devices Market Analysis in Global by Product Type (2021-2030)
  • Figure 5 Plaque Modification Devices Market Analysis in Global by Application (2021-2030)
  • Figure 6 Plaque Modification Devices Market Analysis in Global by End User (2021-2030)
  • Figure 7 Plaque Modification Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 8 Plaque Modification Devices Market Analysis in North America (2021-2030)
  • Figure 9 Plaque Modification Devices Market Analysis in North America by Product Type (2021-2030)
  • Figure 10 Plaque Modification Devices Market Analysis in North America by Application (2021-2030)
  • Figure 11 Plaque Modification Devices Market Analysis in North America by End User (2021-2030)
  • Figure 12 Plaque Modification Devices Market Analysis in North America by Country (2021-2030)
  • Figure 13 Plaque Modification Devices Market Analysis in the US (2021-2030)
  • Figure 14 Plaque Modification Devices Market Analysis in Canada (2021-2030)
  • Figure 15 Plaque Modification Devices Market Analysis in Mexico (2021-2030)
  • Figure 16 Plaque Modification Devices Market Analysis in Europe (2021-2030)
  • Figure 17 Plaque Modification Devices Market Analysis in Europe by Product Type (2021-2030)
  • Figure 18 Plaque Modification Devices Market Analysis in Europe by Application (2021-2030)
  • Figure 19 Plaque Modification Devices Market Analysis in Europe by End User (2021-2030)
  • Figure 20 Plaque Modification Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 21 Plaque Modification Devices Market Analysis in France (2021-2030)
  • Figure 22 Plaque Modification Devices Market Analysis in Germany (2021-2030)
  • Figure 23 Plaque Modification Devices Market Analysis in the UK (2021-2030)
  • Figure 24 Plaque Modification Devices Market Analysis in Italy (2021-2030)
  • Figure 25 Plaque Modification Devices Market Analysis in Spain (2021-2030)
  • Figure 26 Plaque Modification Devices Market Analysis in Russia (2021-2030)
  • Figure 27 Plaque Modification Devices Market Analysis in Rest of Europe (2021-2030)
  • Figure 28 Plaque Modification Devices Market Analysis in Asia-Pacific (2021-2030)
  • Figure 29 Plaque Modification Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Figure 30 Plaque Modification Devices Market Analysis in Asia-Pacific by Application (2021-2030)
  • Figure 31 Plaque Modification Devices Market Analysis in Asia-Pacific by End User (2021-2030)
  • Figure 32 Plaque Modification Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 33 Plaque Modification Devices Market Analysis in China (2021-2030)
  • Figure 34 Plaque Modification Devices Market Analysis in Japan (2021-2030)
  • Figure 35 Plaque Modification Devices Market Analysis in India (2021-2030)
  • Figure 36 Plaque Modification Devices Market Analysis in Australia (2021-2030)
  • Figure 37 Plaque Modification Devices Market Analysis in South Korea (2021-2030)
  • Figure 38 Plaque Modification Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 39 Plaque Modification Devices Market Analysis in Rest of World (2021-2030)
  • Figure 40 Plaque Modification Devices Market Analysis in Rest of World by Product Type (2021-2030)
  • Figure 41 Plaque Modification Devices Market Analysis in Rest of World by Application (2021-2030)
  • Figure 42 Plaque Modification Devices Market Analysis in Rest of World by End User (2021-2030)
  • Figure 43 Plaque Modification Devices Market Analysis in Rest of World by Country (2021-2030)
  • Figure 44 Plaque Modification Devices Market Analysis in the Middle East (2021-2030)
  • Figure 45 Plaque Modification Devices Market Analysis in Africa (2021-2030)
  • Figure 46 Plaque Modification Devices Market Analysis in South America (2021-2030)
  • Figure 47 Market Drivers
  • Figure 48 Market Barriers
  • Figure 49 Market Opportunities
  • Figure 50 PORTER's Five Force Analysis
目次
Product Code: DIMDCL0326

Plaque Modification Devices Market By Product Type (Atherectomy Devices, Thrombectomy Devices, Chronic Total Occlusion (CTO) Devices, Embolic Protection Devices, Others), By Application (Coronary Artery Diseases, Peripheral Artery Diseases, Neurovascular Diseases), By End-User (Hospitals, Ambulatory Surgical Centres, Others), and by geography is expected to expand at a constant CAGR forecast till 2030 owing to the rising prevalence of lifestyle-associated disorders and increase in plaque modification approval and launches

The global plaque modification devices market was valued at USD 1.21 billion in 2023, growing at a CAGR of 8.09% during the forecast period from 2024 to 2030, in order to reach USD 1.93 billion by 2030. Plaques are fatty waxy substance that deposits in the walls of the artery. These depositions can narrow the artery and reduce the blood flow. Sometimes, plaques can also rupture and create a blood clot at the rupture site. The increase in demand for plaque modification devices is predominantly attributed to the continuous expansion of the old age population across the globe, rising sedentary lifestyle and associated disorders, increase in obesity among the population, worldwide, among others which are the major risk factors for developing arterial plaques. In addition, approval and launch of plaque modification devices, strategic business activities among key players for market expansion in plaque modification products, among others are some of the factors expected to drive the global plaque modification devices market.

Plaque Modification Devices Market Dynamics:

The market for plaque modification devices is gaining momentum at present due to the growing prevalence of lifestyle-associated disorders such as diabetes and hypertension. For instance, diabetes and hypertension both are considered major risk factors that may lead to the development of plaques in an individual and can lead to severe disorders such as coronary artery diseases, peripheral artery diseases, aneurysms, and others. According to the statistics published by the International Diabetes Federation (IDF) Diabetes Atlas 2022 tenth Edition, there were 537 million adults (20-79 years) were living with diabetes in the year 2023 which was projected to increase to 643 million by 2030 and 783 million by 2045.

Furthermore, as per the data revealed by the World Health Organization (WHO) in the year 2023, an estimated 1.28 billion adults aged 30-79 years worldwide had hypertension in the same year. Thus, escalating diabetes and hypertension among people worldwide could be potential factors for the market growth of plaque modification devices.

Additionally, age is a significant factor in plaque growth. According to the National Institute on Aging, many heart diseases are caused by atherosclerosis, which is the build-up of fatty deposits, or plaques, in the walls of the coronary arteries over many years and advancing age, increasing the risk of developing atherosclerosis. For instance, according to the United Nations, World Population Ageing 2020 Highlights, globally, there were an estimated 727 million persons aged 65 years or over in the year 2020.

Moreover, the approval of technologically advanced plaque removal devices in different regions across the globe would also contribute to the growth of the plaque modification devices market. For instance, in May 2018, Avinger, Inc. received FDA clearance for its next-generation Pantheris® Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of peripheral artery disease.

Thus, all the above-mentioned factors are expected to surge the demand for plaque modulation devices in the forthcoming years.

With the outbreak of the COVID-19 pandemic, the demand for plaque modification devices in the market decreased. This was because many routine procedures and outpatient visits were temporarily suspended and global healthcare facilities were temporarily focused on managing the burden of COVID-19 patients during the initial lockdown period. However, owing to the approval and administration of numerous COVID-19 vaccines across the globe in the second half of 2020, there was a significant improvement in the resumption of activities across various domains, including healthcare services, thereby paving the way for a sound period of recovery for the plaque modification devices market.

However, the strict regulatory approval process for the plaque modification devices and complications associated with devices and surgical procedures are likely to impede the plaque modification devices market growth.

Plaque Modification Devices Market Segment Analysis:

Plaque Modification Devices Market By Product Type (Atherectomy Devices, Thrombectomy Devices, Chronic Total Occlusion (CTO) Devices, Embolic Protection Devices, Others), By Application (Coronary Artery Diseases, Peripheral Artery Diseases, Neurovascular Diseases), By End-User (Hospitals, Ambulatory Surgical Centres, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the plaque modification devices product type segment, the atherectomy devices are anticipated to hold a significant share during the forecasted period. This is owing to the availability of different atherectomy devices such as directional atherectomy systems, orbital atherectomy systems, rotational atherectomy systems, and others in the market. In addition, advantages such as better clinical outcomes as compared to primary stenting during angioplasty and cost-effectiveness of the procedure will further raise their demand.

Moreover, the rising focus of key players towards the development of atherectomy devices and their launch is also projected to drive the segmental growth of plaque modification devices. For instance, Cardiovascular Systems Inc. received FDA approval for Diamondback 360® Peripheral Orbital Atherectomy System and the Diamondback 360® Stealth Orbital Atherectomy system on September 14, 2022.

Furthermore, initiatives by manufacturers to revive old product lines to increase offerings for atherectomy devices will boost the segmental market in the upcoming years. For instance, in August 2022, the FDA cleared the 510(k) application of Medtronic's TurboHawk Plus Directional Atherectomy System, an updated version of its older and largely phased out atherectomy device.

Thus, all the factors would augment the segmental market of plaque modification devices in the forthcoming years.

North America is expected to dominate the overall Plaque Modification Devices Market:

Among all the regions, North America is expected to occupy a significant share in the overall plaque modification devices market during the forecasted period. This domination is due to the increase in the patient population in the region. Moreover, a rise in sedentary lifestyle and increase in obesity among the population is also expected to raise the demand for plaque modification devices as obesity is one of the risk factors for carotid plaque destabilization. In addition, the rise in smoking in the region and the presence of an advanced healthcare system for proper arterial plaque management, among others are anticipated to bolster the market for plaque modification devices in the upcoming years.

For instance, as per the data provided by the Centers for Disease Control and Prevention (CDC) in the year 2023, about 18.2 million adults age 20 and older have coronary artery diseases (CAD) which are approximately 6.7% of the total US population. Also, as per the CDC 2022, approximately 6.5 million people age 40 and older in the US had the peripheral arterial disease (PAD) in the year 2023.

Additionally, as per the aforementioned source, an estimated 34.1 million adults in the US smoke cigarettes, and more than 16 million Americans lived with a smoking-related disease in the year 2019. Furthermore, as per the Government of Canada 2020 data, the prevalence of cigarette smoking in 2019 in Canada was 12% (3.7 million). Excessive smoking increase the formation of plaque in blood vessels thus it may raise the demand for plaque modification devices in the forthcoming years.

Moreover, the presence of key players active in manufacturing plaque modification devices and their strategic business activities for the expansion of the market would also contribute to the growth of plaque modification devices in the region in the upcoming years. For instance, on June 01, 2020, BD (Becton, Dickinson, and Company) completed the acquisition of Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy devices that treat peripheral arterial disease (PAD) and venous disease.

Hence, the interplay of all the aforementioned factors is anticipated to propel the regional plaque modification devices during the forecasted period.

Plaque Modification Devices Market Key Players:

Some of the key market players operating in the Plaque Modification Devices market include Boston Scientific Corporation, Medtronic, Abbott, Shockwave Medical, Inc., Cardiovascular Systems, Inc., AngioDynamics, Inc., Avinger, REX MEDICAL, Ra Medical Systems, Koninklijke Philips N.V., Becton, Dickinson and Company, Penumbra, Inc., Stryker, Microvention, Inc., Johnson & Johnson, ARGON MEDICAL., Inari Medical, Nitiloop, Soundbite Medical Solutions, Rontis Corporation, among others.

Recent Developmental Activities in the Plaque Modification Devices Market:

In September 2022, Abbott acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots.

In February 2022, Shockwave Medical, Inc. a medical device company focused on the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, received Pre-Market Approval from the US FDA for the company's sonic pressure wave device to treat severely calcified coronary artery disease.

In January 2022, Cardiovascular Systems, Inc. received CE Mark for Diamondback 360® Coronary Orbital Atherectomy System.

In September 2020, AngioDynamics, Inc. commercially launched the Auryon Atherectomy System, a newly-developed innovative technology for the treatment of Peripheral Artery Disease (PAD), including Critical Limb Ischemia (CLI) and In-Stent Restenosis (ISR).

Key Takeaways from the Plaque Modification Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Plaque Modification Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Plaque Modification Devices Market.

Various opportunities available for the other competitor in the Plaque Modification Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Plaque Modification Devices market growth in the coming future?

Target Audience who can be benefited from the Plaque Modification Devices Market Report Study

Plaque Modification Devices providers

Research organizations and consulting companies

Plaque Modification Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Plaque Modification Devices

Various End-users want to know more about the Plaque Modification Devices Market and the latest technological developments in the Plaque Modification Devices market.

Frequently Asked Questions for the Plaque Modification Devices Market:

1. What are Plaque Modification Devices?

Plaque in the arteries is a deposition of a fatty, waxy substance that can narrow the artery and reduce blood flow. Plaque modification devices are intended for the removal of plaque and other debris from the arteries, which carry the blood to the heart and brain.

2. What is the market for Global Plaque Modification Devices?

The global plaque modification devices market was valued at USD 1.21 billion in 2023, growing at a CAGR of 8.09% during the forecast period from 2024 to 2030, in order to reach USD 1.93 billion by 2030.

3. What are the drivers for the Global Plaque Modification Devices?

The major factors driving the demand for Plaque Modification Devices are the growing old age population burden, increase in the prevalence of lifestyle disorders such as diabetes, hypertension, and others, increase in technological advancement in the product arena along with an increase in product approvals and launches.

4. What are the key players operating in Global Plaque Modification Devices?

Some of the key market players operating in the Plaque Modification Devices market include Boston Scientific Corporation, Medtronic, Abbott, Shockwave Medical, Inc., Cardiovascular Systems, Inc., AngioDynamics, Inc., Avinger, REX MEDICAL, Ra Medical Systems, Koninklijke Philips N.V., Becton, Dickinson and Company, Penumbra, Inc., Stryker, Microvention, Inc., Johnson & Johnson, ARGON MEDICAL., Inari Medical, Nitiloop, Soundbite Medical Solutions, Rontis Corporation, among others.

5. Which region has the highest share in the Plaque Modification Devices market?

Among all the regions, North America is expected to occupy a significant share in the overall plaque modification devices market during the forecasted period, 2024-2030. This domination is due to the increase in the patient population in the region. Moreover, a rise in sedentary lifestyle and increase in obesity among the population is also expected to raise the demand for plaque modification devices as obesity is one of the risk factors for carotid plaque destabilization. In addition, the rise in smoking in the region and the presence of an advanced healthcare system for proper arterial plaque management, among others are anticipated to bolster the market for plaque modification devices in the upcoming years.

Table of Contents

1.Plaque Modification Devices Market Report Introduction

2.Plaque Modification Devices Market Executive summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Plaque Modification Devices Market Key factors analysis

  • 4.1 Plaque Modification Devices Market Drivers
    • 4.1.1 Rising sedentary lifestyle and Increasing prevalence of lifestyle-associated disorders such as diabetes, hypertension, obesity, among others
    • 4.1.2 Growing geriatric Population
    • 4.1.3 Increasing preferences for minimally invasive surgeries
    • 4.1.4 Growing approvals and launch of technologically advanced products
  • 4.2 Plaque Modification Devices Market Restraints and Challenges
    • 4.2.1 High cost and complications associated with the plaque modification devices and surgery
    • 4.2.2 The stringent regulatory approval process
  • 4.3 Plaque Modification Devices Market Opportunities
    • 4.3.1 Growth Opportunities in low-and middle-income nations
    • 4.3.2 Strategic business activities among key players will provide market expansion opportunities

5. Plaque Modification Devices Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Plaque Modification Devices Market

7. Plaque Modification Devices Market layout

  • 7.1 By Product Type
    • 7.1.1 Atherectomy devices
    • 7.1.2 Thrombectomy devices
    • 7.1.3 Chronic Total Occlusion (CTO) Devices
    • 7.1.4 Embolic Protection Devices
    • 7.1.5 Others
  • 7.2 By Application
    • 7.2.1 Coronary artery diseases
    • 7.2.2 Peripheral artery diseases
    • 7.2.3 Neurovascular diseases
  • 7.3 End-User
    • 7.3.1 Hospitals
    • 7.3.2 Ambulatory Surgical Centers
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 North America Plaque Modification Devices Market, by Product Type
      • 7.4.1.2 North America Plaque Modification Devices Market, by Application
      • 7.4.1.3 North America Plaque Modification Devices Market, by End User
      • 7.4.1.4 North America Plaque Modification Devices Market, by Country
      • 7.4.1.4.1 United States
      • 7.4.1.4.2 Canada
      • 7.4.1.4.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 Europe Plaque Modification Devices Market, by Product Type
      • 7.4.2.2 Europe Plaque Modification Devices Market, by Application
      • 7.4.2.3 Europe Plaque Modification Devices Market, by End User
      • 7.4.2.4 Europe Plaque Modification Devices Market, by Country
      • 7.4.2.4.1 France
      • 7.4.2.4.2 Germany
      • 7.4.2.4.3 United Kingdom
      • 7.4.2.4.4 Italy
      • 7.4.2.4.5 Spain
      • 7.4.2.4.6 Russia
      • 7.4.2.4.7 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 Asia-Pacific Plaque Modification Devices Market, by Product Type
      • 7.4.3.2 Asia-Pacific Plaque Modification Devices Market, by Application
      • 7.4.3.3 Asia-Pacific Plaque Modification Devices Market, by End User
      • 7.4.3.4 Asia-Pacific Plaque Modification Devices Market, by Country
      • 7.4.3.4.1 China
      • 7.4.3.4.2 Japan
      • 7.4.3.4.3 India
      • 7.4.3.4.4 Australia
      • 7.4.3.4.5 South Korea
      • 7.4.3.4.6 Rest of Asia Pacific
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 RoW Plaque Modification Devices Market, by Product Type
      • 7.4.4.2 RoW Plaque Modification Devices Market, by Application
      • 7.4.4.3 RoW Plaque Modification Devices Market, by End User
      • 7.4.4.4 RoW Plaque Modification Devices Market, by Region
      • 7.4.4.4.1 Middle East
      • 7.4.4.4.2 Africa
      • 7.4.4.4.3 South America

8. Plaque Modification Devices Global Company Share Analysis - Key 3-5 Companies

9. Plaque Modification Devices Company and Product Profiles

  • 9.1 Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Boston Scientific Corporation
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 Abbott
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Shockwave Medical, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Cardiovascular Systems, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 AngioDynamics, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 Avinger
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 REX MEDICAL
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 Ra Medical Systems
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Koninklijke Philips N.V.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Rontis Corporation
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 Becton, Dickinson and Company
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Penumbra, Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 Stryker
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 Microvention, Inc.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 Johnson & Johnson
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 ARGON MEDICAL.
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Inari Medical
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy
  • 9.19 Nitiloop
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5. Entropy
  • 9.20 Soundbite Medical Solutions
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us